Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEBRA-COLON: Zebrafish Avatars for Colon Cancer Treatment Evaluation
NCT06270017Phase 2Recruiting
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial. Primary endpoint: Tumour growth at 3 days. Started Jan 2022; status: recruiting.
Beyond the preview
Go deeper on NCT06270017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06270017.